labiotech1h
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...
Tempering Positive Sentiment Of AI In Biotech
AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...
Santa Rosa Press Democrat11h
Gov. Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...
FDA bans red dye No. 3 from foods
U.S. regulators are banning the dye called Red 3 from the food supply. The move comes nearly 35 years after the dye was ...
CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers
CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...
Becker's Hospital Review12h
Watchdog flags flaws in FDA's fast-track drug approvals
The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...
Summit County13h
Could synthetic psilocybin be the next big thing in mental health? Colorado thinks so.
A state bill that could allow for synthetic psilocybin to be prescribed in Colorado cleared a key committee hearing on ...
When must Red Dye No. 3 be removed from US foods after FDA ban? Latest timing
Regulators banned a dye called Red 3 from the U.S. food supply, but the timing for its removal won't be immediate.
Lilly gets FDA approval for Omvoh for Crohn's disease
Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as mirikizumab-mrkz, for the treatment of ...
Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
Eli Lilly’s Omvoh for Crohn’s disease approved by FDA
Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh ...
US FDA approves expanded use of Lilly's bowel disease drug
Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...